Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
IMMU-140, a Novel SN-38 Antibody-Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma.
Mol Cancer Ther. 2018 Jan;17(1):150-160. doi: 10.1158/1535-7163.MCT-17-0354. Epub 2017 Nov 13.
Mol Cancer Ther. 2018.
PMID: 29133623
Combining ABCG2 Inhibitors with IMMU-132, an Anti-Trop-2 Antibody Conjugate of SN-38, Overcomes Resistance to SN-38 in Breast and Gastric Cancers.
Chang CH, Wang Y, Zalath M, Liu D, Cardillo TM, Goldenberg DM.
Chang CH, et al.
Mol Cancer Ther. 2016 Aug;15(8):1910-9. doi: 10.1158/1535-7163.MCT-16-0219. Epub 2016 May 20.
Mol Cancer Ther. 2016.
PMID: 27207776
Item in Clipboard
Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer.
Cardillo TM, Rossi DL, Zalath MB, Liu D, Arrojo R, Sharkey RM, Chang CH, Goldenberg DM.
Cardillo TM, et al. Among authors: zalath mb.
Oncotarget. 2020 Oct 27;11(43):3849-3862. doi: 10.18632/oncotarget.27766. eCollection 2020 Oct 27.
Oncotarget. 2020.
PMID: 33196706
Free PMC article.
Item in Clipboard
Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell lines.
Stein R, Smith MR, Chen S, Zalath M, Goldenberg DM.
Stein R, et al.
Clin Cancer Res. 2009 Apr 15;15(8):2808-17. doi: 10.1158/1078-0432.CCR-08-1953. Epub 2009 Apr 7.
Clin Cancer Res. 2009.
PMID: 19351768
Free PMC article.
Item in Clipboard
Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.
Cardillo TM, Zalath MB, Arrojo R, Sharkey RM, Govindan SV, Chang CH, Goldenberg DM.
Cardillo TM, et al. Among authors: zalath mb.
Oncotarget. 2024 Feb 22;15:144-158. doi: 10.18632/oncotarget.28559.
Oncotarget. 2024.
PMID: 38386805
Free PMC article.
Item in Clipboard
Cite
Cite